171 related articles for article (PubMed ID: 18266274)
1. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination.
Silva CL; Bonato VL; Lima VM; Faccioli LH; Leão SC
Immunology; 1999 Aug; 97(4):573-81. PubMed ID: 10457209
[TBL] [Abstract][Full Text] [Related]
3. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.
Mittrücker HW; Steinhoff U; Köhler A; Krause M; Lazar D; Mex P; Miekley D; Kaufmann SH
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12434-9. PubMed ID: 17640915
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis antigen 85B modifies BCG-induced antituberculosis immunity and favors pathogen survival.
Piccaro G; Aquino G; Gigantino V; Tirelli V; Sanchez M; Iorio E; Matarese G; Cassone A; Palma C
J Leukoc Biol; 2024 May; 115(6):1053-1069. PubMed ID: 38242866
[TBL] [Abstract][Full Text] [Related]
5. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.
Beveridge NE; Price DA; Casazza JP; Pathan AA; Sander CR; Asher TE; Ambrozak DR; Precopio ML; Scheinberg P; Alder NC; Roederer M; Koup RA; Douek DC; Hill AV; McShane H
Eur J Immunol; 2007 Nov; 37(11):3089-100. PubMed ID: 17948267
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes.
Kamath AT; Groat NL; Bean AG; Britton WJ
Clin Exp Immunol; 2000 Jun; 120(3):476-82. PubMed ID: 10844526
[TBL] [Abstract][Full Text] [Related]
7. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.
Sadagopal S; Braunstein M; Hager CC; Wei J; Daniel AK; Bochan MR; Crozier I; Smith NE; Gates HO; Barnett L; Van Kaer L; Price JO; Blackwell TS; Kalams SA; Kernodle DS
PLoS One; 2009; 4(5):e5531. PubMed ID: 19436730
[TBL] [Abstract][Full Text] [Related]
8. Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.
Henao-Tamayo MI; Obregón-Henao A; Arnett K; Shanley CA; Podell B; Orme IM; Ordway DJ
J Leukoc Biol; 2016 Apr; 99(4):605-17. PubMed ID: 26590147
[TBL] [Abstract][Full Text] [Related]
9. A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis.
O'Hara JM; Wakabayashi S; Siddiqi N; Cheung E; Babunovic GH; Thompson CM; Lu YJ; Rubin EJ; Malley R; Zhang F
mBio; 2023 Feb; 14(1):e0361122. PubMed ID: 36749098
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.
Abolhassani M; Lagranderie M; Chavarot P; Balazuc AM; Marchal G
Infect Immun; 2000 Oct; 68(10):5657-62. PubMed ID: 10992467
[TBL] [Abstract][Full Text] [Related]
11. Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells.
Christensen AD; Skov S; Kvist PH; Haase C
Clin Exp Immunol; 2015 Mar; 179(3):485-99. PubMed ID: 25302741
[TBL] [Abstract][Full Text] [Related]
12. IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guérin Vaccination Sustains Long-Term Protection against
Dwivedi V; Gautam S; Headley CA; Piergallini T; Torrelles JB; Turner J
J Immunol; 2022 Mar; 208(6):1406-1416. PubMed ID: 35181640
[No Abstract] [Full Text] [Related]
13. Early T-cell responses in tuberculosis immunity.
Winslow GM; Cooper A; Reiley W; Chatterjee M; Woodland DL
Immunol Rev; 2008 Oct; 225():284-99. PubMed ID: 18837789
[TBL] [Abstract][Full Text] [Related]
14. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns.
Kagina BM; Abel B; Scriba TJ; Hughes EJ; Keyser A; Soares A; Gamieldien H; Sidibana M; Hatherill M; Gelderbloem S; Mahomed H; Hawkridge A; Hussey G; Kaplan G; Hanekom WA;
Am J Respir Crit Care Med; 2010 Oct; 182(8):1073-9. PubMed ID: 20558627
[TBL] [Abstract][Full Text] [Related]
15. Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis.
Feng CG; Bean AG; Hooi H; Briscoe H; Britton WJ
Infect Immun; 1999 Jul; 67(7):3242-7. PubMed ID: 10377097
[TBL] [Abstract][Full Text] [Related]
16. Inability of the BCG vaccine to protect mice of the H2
Korotetskaya M; Baikuzina P; Apt A
Tuberculosis (Edinb); 2023 Dec; 143():102429. PubMed ID: 38011759
[TBL] [Abstract][Full Text] [Related]
17. Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.
Harris SA; White A; Stockdale L; Tanner R; Sibley L; Sarfas C; Meyer J; Peter J; O'Shea MK; Manjaly Thomas ZR; Hamidi A; Satti I; Dennis MJ; McShane H; Sharpe S
Tuberculosis (Edinb); 2018 Jan; 108():99-105. PubMed ID: 29523335
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.
Djuardi Y; Sartono E; Wibowo H; Supali T; Yazdanbakhsh M
PLoS One; 2010 Nov; 5(11):e14066. PubMed ID: 21124909
[TBL] [Abstract][Full Text] [Related]
19. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
[TBL] [Abstract][Full Text] [Related]
20. CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature.
Singhania A; Dubelko P; Kuan R; Chronister WD; Muskat K; Das J; Phillips EJ; Mallal SA; Seumois G; Vijayanand P; Sette A; Lerm M; Peters B; Lindestam Arlehamn C
EBioMedicine; 2021 Dec; 74():103746. PubMed ID: 34902786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
